1991
Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
Colson ER, Horwitz RI, Bia FJ, Viscoli CM. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. JAMA Internal Medicine 1991, 151: 709-13. PMID: 2012453, DOI: 10.1001/archinte.151.4.709.Peer-Reviewed Original ResearchConceptsZidovudine therapyDosage reductionAdverse outcomesHuman immunodeficiency virus type 1 (HIV-1) infectionClinical practiceHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Observational cohort studyHuman immunodeficiency virusTreatment of patientsType 1 infectionVirus type 1Zidovudine dosageCohort studyMost patientsImmunodeficiency virusBaseline cytopeniasTreatment outcomesPatterns of usePatientsTherapyType 1Dosage changesMonths
1980
Western Equine Encephalitis Mimicking Herpes Simplex Encephalitis
Bia F, Thornton G, Main A, Fong C, Hsiung GD. Western Equine Encephalitis Mimicking Herpes Simplex Encephalitis. JAMA 1980, 244: 367-369. PMID: 7190194, DOI: 10.1001/jama.1980.03310040049029.Peer-Reviewed Case Reports and Technical NotesConceptsHerpes simplex encephalitisBrain biopsy tissueSimplex encephalitisBrain biopsySevere encephalitisFocal findingsTherapeutic responsePatient's conditionNewborn miceAntiviral agentsBiopsy tissueEncephalitisLaboratory diagnosisWestern equine encephalitisMurine coronavirusHuman illnessEquine encephalitisDiagnostic virologyTissue culturePatientsBiopsyVidarabineIllnessMiceDiagnosis